23 results
8-K
EX-99.1
RXST
RxSight, Inc.
5 Aug 24
Rxsight, Inc. Reports Second Quarter 2024 Financial Results
4:10pm
it enables. As we move forward, we remain dedicated to expanding our presence and driving innovation within the global premium IOL market.”
Second … for excellent clinical outcomes and personalized approach, expanding the company’s presence, driving innovation within the global premium IOL market
10-K
tzx6u4v7y7di
8 Mar 22
Annual report
4:31pm
10-Q
qa4m6pj11
9 Sep 21
Quarterly report
5:01pm
424B4
3ivycwj7e boi9raf
30 Jul 21
Prospectus supplement with pricing info
4:17pm
S-1/A
vjw4j1kxmi p3aj
26 Jul 21
IPO registration (amended)
8:02am
S-1
lnkvg0
9 Jul 21
IPO registration
3:58pm
S-1
EX-10.6
4fqt6c97dh
9 Jul 21
IPO registration
3:58pm
S-1
EX-10.8
qg3ojyxm
9 Jul 21
IPO registration
3:58pm
S-1
EX-10.10
0p77wf12cp504ghg
9 Jul 21
IPO registration
3:58pm